Localization of cytochrome P4501A1 and covalent binding of a mutagenic heterocyclic amine in blood vessel endothelia of rodents

Toxicology

Volumn 129, Issue 2-3, 1998, Pages 145-156

  Annas, Anita ^a   Brittebo, Eva B ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

CYP1A1; Endothelium; Food mutagen; Heart; Immunohistochemistry; Lymph node; Muscle; Uterus

Indexed keywords

CYTOCHROME P450; HETEROCYCLIC AMINE; MUTAGENIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; COVALENT BOND; ENDOTHELIUM CELL; FEMALE; FOOD; HEART MUSCLE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MOUSE; MYOMETRIUM; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE;

ANIMALS; AUTORADIOGRAPHY; BETA-NAPHTHOFLAVONE; CARBOLINES; CYTOCHROME P-450 CYP1A1; ENDOTHELIUM, VASCULAR; FEMALE; IMMUNOHISTOCHEMISTRY; MICE; MUTAGENS; RABBITS; RATS; RATS, SPRAGUE-DAWLEY;

RODENTIA;

EID: 0032555775     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(98)00087-0     Document Type: Article

References (56)

1. Abraham N.G., Pinto A., Levere R.D., Mullane K. Identification of heme oxygenase and cytochrome P450 in the rabbit heart. J. Mol. Cell. Cardiol. 19:1987;73-81.
2. Abraham N.G., Pinto A., Mullane K.M., Levere R.D., Spokas E. Presence of cytochrome P450-dependent monooxygenase in intimal cells of the hog aorta. Hypertension. 7:1985;899-904.
3. Adeagbo A.S. Endothelium-derived hyperpolarizing factor: characterization as a cytochrome P4501A-linked metabolite of arachidonic acid in perfused rat mesenteric prearteriolar bed. Am. J. Hypertens. 10:1997;763-771.
4. Anderson L.M., Ward J.M., Park S.S., Jones A.B., Junker J.L., Gelboin H.V., Rice J.M. Immunohistochemical determination of inducibility phenotype with a monoclonal antibody to a methylcholanthrene-inducible isozyme of cytochrome P450. Cancer Res. 47:1987;6079-6085.
5. Annas A., Brunström B., Brandt I., Brittebo E.B. Induction of ethoxyresorufin O-deethylase (EROD) and endothelial activation of the heterocyclic amine Trp-P-1 in bird embryo hearts. Arch. Toxicol. 72:1998;411-419.
6. Anttila S., Hietanen E., Vainio H., Camus A.M., Gelboin H.V., Park S.S., Heikkila L., Karjalainen A., Bartsch H. Smoking and peripheral type of cancer are related to high levels of pulmonary cytochrome P450IA in lung cancer patients. Int. J. Cancer. 47:1991;681-685.
7. Anttila S., Vainio H., Hietanen E., Camus A.M., Malaveille C., Brun G., Husgafvel Pursiainen K., Heikkila L., Karjalainen A., Bartsch H. Immunohistochemical detection of pulmonary cytochrome P450IA and metabolic activities associated with P450IA1 and P450IA2 isozymes in lung cancer patients. Environ. Health Perspect. 98:1992;179-182.
8. Bond J.A., Kocan R.M., Benditt E.P., Juchau M.R. Metabolism of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene in cultured human fetal aortic smooth muscle cells. Life Sci. 25:1979;425-430.
9. Brittebo E.B. Metabolic activation of phenacetin in rat nasal mucosa: Dose dependent binding to the glands of Bowman. Cancer Res. 47:1987;1449-1456.
10. Brittebo E.B. Metabolic activation of the food mutagen Trp-P-1 in endothelial cells of heart and kidney in cytochrome P450-induced mice. Carcinogenesis. 15:1994;667-672.
11. Brittebo E.B., Brandt I. Metabolic activation of the food mutagen 3-amino-1,4-dimethyl-5H-pyrido-[4,3-b]indole (Trp-P-1) in endothelial cells of cytochrome P450-induced mice. Cancer Res. 54:1994;2887-2894.
12. Brittebo E.B., Brandt I. Cell- and tissue-specific metabolic activation of chemicals as determined by autoradiography. In vivo and in vitro correlations. Toxicol. In Vitro. 11:1997;417-426.
13. Celander M., Weisbrod R., Stegeman J.J. Glucocorticoid potentiation of cytochrome P4501A1 induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin in porcine and human endothelial cells in culture. Biochem. Biophys. Res. Commun. 232:1997;749-753.
14. Chen G., Cheung D.W. Modulation of endothelium-dependent hyperpolarization and relaxation to acetylcholine in rat mesenteric artery by cytochrome P450 enzyme activity. Circ. Res. 79:1996;827-833.
15. Coceani F., Kelsey L., Ackerley C., Rabinovitch M., Gelboin H. Cytochrome P450 during ontogenic development: occurence in the ductus arteiosus and other tissues. Can. J. Physiol. Pharmacol. 72:1994;217-226.
16. Crosbie S.J., Blain P.G., Williams F.M. An investigation into the role of rat skeletal muscle as a site for xenobiotic metabolism using microsomes and isolated cells. Hum. Exp. Toxicol. 16:1997;138-145.
17. Edwards R.J., Singleton A.M., Murray B.P., Davies D.S., Boobis A.R. Short synthetic peptides exploited for reliable and specific targeting of antibodies to the C-termini of cytochrome P450 enzymes. Biochem. Pharmacol. 49:1995;39-47.
18. Falck J.R., Lumin S., Blair I., Dishman E., Martin M.V., Waxman D.J., Guengerich F.P., Capdevila J.H. Cytochrome P450-dependent oxidation of arachidonic acid to 16-, 17-, and 18-hydroxyeicosatetraenoic acids. J. Biol. Chem. 265:1990;10244-10249.
19. Farin F.M., Pohlman T.H., Omiecinski C.J. Expression of cytochrome P450s and microsomal epoxide hydrolase in primary cultures of human umbilical vein endothelial cells. Toxicol. Appl. Pharmacol. 124:1994;1-9.
20. Feletou M., Vanhoutte P.M. Endothelium-derived hyperpolarizing factor. Clin. Exp. Pharmacol. Physiol. 23:1996;1082-1090.
21. Forkert P.G., Lord J.A., Parkinson A. Alterations in expression of CYP1A1 and NADPH-cytochrome P450 reductase during lung tumor development in SWR/J mice. Carcinogenesis. 17:1996;127-132.
22. Forkert P.G., Vessey M.L., Park S.S., Gelboin H.V., Cole S.P. Cytochromes P450 in murine lung. An immunohistochemical study with monoclonal antibodies. Drug. Metab. Dispos. 17:1989;551-555.
23. Foster J.R., Elcombe C.R., Boobis A.R., Davies D.S., Sesardic D., McQuade J., Robson R.T., Hayward C., Lock E.A. Immunocytochemical localization of cytochrome P450 in hepatic and extra-hepatic tissues of the rat with a monoclonal antibody against cytochrome P450c. Biochem. Pharmacol. 35:1986;4543-4554.
24. Fukao M., Hattori Y., Kanno M., Sakuma I., Kitabatake A. Evidence against a role of cytochrome P450-derived arachidonic acid metabolites in endothelium-dependent hyperpolarization by acetylcholine in rat mesenteric artery. Br. J. Pharmacol. 120:1997;439-446.
25. Fulton D., Mahboubi K., McGiff J.C., Quilley J. Cytochrome P450-dependent effects of bradykinin in the rat heart. Br. J. Pharmacol. 114:1995;99-102.
26. Germolec D.R., Henry E.C., Maronpot R., Foley J.F., Adams N.H., Gasiewicz T.A., Luster M.I. Induction of CYP1A1 and ALDH-3 in lymphoid tissues from Fisher 344 rats exposed to 2,3,7,8-tetrachlorodibenzodioxin (TCDD). Toxicol. Appl. Pharmacol. 137:1996;57-66.
27. Giachelli C.M., Majesky M.W., Schwartz S.M. Developmentally regulated cytochrome P4501A1 expression in cultured rat vascular smooth muscle cells. J. Biol. Chem. 266:1991;3981-3986.
28. Gilbertson M., Kubiak T., Ludwig J., Fox G. Great Lakes embryo mortality, edema, and deformities syndrome (GLEMEDS) in colonial fish-eating birds: Similarity to chick-edema disease. J. Toxicol. Environ. Health. 33:1991;455-520.
29. Guengerich F.P., Mason P.S. Immunological comparison of hepatic and extrahepatic cytochromes P450. Mol. Pharmacol. 15:1979;154-164.
30. Guiney P.D., Smolowitz R.M., Peterson R.E., Stegeman J.J. Correlation of 2,3,7,8-tetrachlorodibenzo-p-dioxin induction of cytochrome P4501A in vascular endothelium with toxicity in early life stages of lake trout. Toxicol. Appl. Pharmacol. 143:1997;256-273.
31. Hazinski T.A., Noisin E., Hamon I., De Matteo A. Sheep lung cytochrome P4501A1 (CYP1A1): cDNA cloning and transcriptional regulation by oxygen tension. J. Clin. Invest. 96:1995;2083-2089.
32. Henry T.R., Spitsbergen J.M., Hornung M.W., Abnet C.C., Peterson R.E. Early life stage toxicity of 2,3,7,8 tetrachlorodibenzo-p-dioxin in zebrafish (danio rerio). Toxicol. Appl. Pharmacol. 142:1997;56-68.
33. Husøy A.M., Myers M.S., Willis M.L., Collier T.K., Celander M., Goksøyr A. Immunohistochemical localization of CYP1A and CYP3A-like isozymes in hepatic and extrahepatic tissues of atlantic cod (Gadus morhua L.), a marine fish. Toxicol. Appl. Pharmacol. 129:1994;294-308.
34. Juchau M.R., Bond J.A., Benditt E.P. Aryl 4-monooxygenase and cytochrome P450 in the aorta: possible role in atherosclerosis. Proc. Natl. Acad. Sci. USA. 73:1976;3723-3725.
35. Keith I.M., Olson Jr E.B., Wilson N.M., Jefcoate C.R. Immunological identification and effects of 3-methylcholanthrene and phenobarbital on rat pulmonary cytochrome P450. Cancer. Res. 47:1987;1878-1882.
36. Leaver M.J., Pirrit L., George S.G. Cytochrome P450 1A1 cDNA from plaice (Pleuronectes platessa) and induction of P4501A1 mRNA in various tissues by 3-methylcholantrene and isosafrole. Mol. Marine Biol. Biotechnol. 2:1993;338-345.
37. Manabe S., Wada O. Carcinogenic tryptophan pyrolysis products in the environment. J. Toxicol. Sci. Suppl. 1:1991;63-72.
38. McCallum G.P., Horton J.E., Falkner K.C., Bend J.R. Microsomal cytochrome P4501A1 dependent monooxygenase activity in guinea pig heart: induction, inhibition, and increased activity by addition of exogenous NADPH-cytochrome P450 reductase. Can. J. Physiol. Pharmacol. 71:1993;151-156.
39. Overby L.H., Nishio S., Weir A., Carver G.T., Plopper C.G., Philpot R.M. Distribution of cytochrome P450 1A1 and NADPH-cytochrome P450 reductase in lungs of rabbits treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin: Ultrastructural immunolocalization and in situ hybridization. Mol. Pharmacol. 41:1992;1039-1046.
40. Oyekan A.O., McGiff J.C., Quilley J. Cytochrome P450-dependent vasodilator responses to arachidonic acid in the isolated, perfused kidney of the rat. Circ. Res. 68:1991;958-965.
41. Oyekan A.O., McGiff J.C., Rosencrantz Weiss P., Quilley J. Relaxant responses of rabbit aorta: influence of cytochrome P450 inhibitors. J. Pharmacol. Exp. Ther. 268:1994;262-269.
42. Pinkerton K.E., Peake J.L., Espiritu I., Goldsmith M., Witschi H. Quantitative histology and cytochrome P450 immunocytochemistry of the lung parenchyma following 6 months of exposure strain A/J mice to cigarette sidestream smoke. Inhal. Toxicol. 8:1996;927-945.
43. Pinto A., Abraham A.G., Mullane K.M. Cytochrome P450-dependent monooxygenase activity and endothelial-dependent relaxations induced by arachidonic acid. J. Pharmacol. Exp. Ther. 236:1986;445-451.
44. Popp R., Bauersachs J., Hecker M., Fleming I., Busse R. A transferable, beta naphthoflavone inducible, hyperpolarizing factor is synthesized by native and cultured porcine coronary endothelial cells. J. Physiol. 497:1996;699-709.
45. Pyykkö K., Ala-Uotila S., Jaakola U.M., Lähde M. Aryl hydrocarbon hydroxylase activity in chemically induced and toremifene-treated mammary tumors in rats. Int. J. Cancer. 56:1994;140-145.
46. Rifkind A.B., Muschick H. Benoxaprofen suppression of polychlorinated biphenyl toxicity without alteration of mixed function oxidase function. Nature. 303:1983;524-526.
47. Serabjit-Singh C.J., Bend J.R., Philpot R.M. Cytochrome P450 monooxygenase system. Localization in smooth muscle of rabbit aorta. Mol. Pharmacol. 28:1985;72-79.
48. Shimada T., Hayes C.L., Yamazaki H., Amin S., Hecht S.S., Guengerich F.P., Sutter T.R. Activation of chemically diverse procarcinogens by human cytochrome P4501B1. Cancer Res. 56:1996;2979-2984.
49. Shimada T., Yamazaki H., Mimura M., Wakamiya N., Ueng Y.F., Guengerich F.P., Inui Y. Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal liver and adult lungs. Drug. Metab. Dispos. 24:1996;515-522.
50. Shimada T., Yun C.H., Yamazaki H., Gautier J.C., Beaune P.H., Guengerich F.P. Characterization of human lung microsomal cytochrome P4501A1 and its role in oxidation of chemical carcinogens. Mol. Pharmacol. 41:1992;856-864.
51. Smolowitz R.M., Schultz M.E., Stegeman J.J. Cytochrome P4501A induction in tissues, including olfactory epithelium, of topminnows (Poeciliopsis spp.) by waterborne benzo[a]pyrene. Carcinogenesis. 13:1992;2395-2402.
52. Stegeman J.J., Hahn M.E., Weisbrod R., Woodin B.R., Joy J.S., Najibi S., Cohen R.A. Induction of cytochrome P4501A1 by aryl hydrocarbon receptor agonists in porcine aorta endothelial cells in culture and cytochrome P4501A1 activity in intact cells. Mol. Pharmacol. 47:1995;296-306.
53. Stegeman J.J., Miller M.R., Hinton D.E. Cytochrome P4501A1 induction and localization in endothelium of vertebrate (teleost) heart. Mol. Pharmacol. 36:1989;723-729.
54. Stegeman J.J., Smolowitz R.M., Hahn M.E. Immunohistochemical localization of environmentally induced cytochrome P4501A1 in multiple organs of the marine teleost Stenotomus chrysops (Scup). Toxicol. Appl. Pharmacol. 110:1991;486-504.
55. Sugimura T. Carcinogenicity of mutagenic heterocyclic amines formed during the cooking process. Mut. Res. 150:1985;33-41.
56. Vanheel B., Van de Voorde J. Evidence against the involvement of cytochrome P450 metabolites in endothelium-dependent hyperpolarization of the rat main mesenteric artery. J. Physiol. Lond. 501:1997;331-341.